Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.

Neurological research - 1 Jul 2008

Li Shouwei, Jiang Tao, Li Guilin, Wang Zhongcheng

Abstract excerpt

OBJECTIVE: This study was designed to assess the clinical outcomes of MGMT low expression glioblastomas with different p53 statuses to the treatment of temozolomide capsule chemotherapy. METHODS: In this retrospective study, glioblastomas with low MGMT expression receiving surgical resection, rad...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Chemotherapy, Adjuvant
Share to Dacarbazine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Radiotherapy

Share to Temozolomide

Source

Identifiers

PMID: 18647495
DOI: 10.1179/174313208X297913

Genes

MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18647495-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.PMID 18647495Read ↗

Immunohistochemical assessment of MGMT expression and p53 mutation in glioblastoma multiforme.Semantic proximity Read ↗

Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase.Semantic proximity Read ↗

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.Semantic proximity Read ↗

O6-methylguanine-DNA methyltransferase gene(MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulationSemantic proximity Read ↗

Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastomaSemantic proximity Read ↗

THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMASSemantic proximity Read ↗

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 ExpressionSemantic proximity Read ↗

MGMT methylation: A marker of response to temozolomide in low‐grade gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.